Maria Warwas

784 total citations
59 papers, 624 citations indexed

About

Maria Warwas is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research. According to data from OpenAlex, Maria Warwas has authored 59 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Clinical Biochemistry and 10 papers in Cancer Research. Recurrent topics in Maria Warwas's work include Advanced Glycation End Products research (13 papers), Chronic Kidney Disease and Diabetes (8 papers) and Protease and Inhibitor Mechanisms (6 papers). Maria Warwas is often cited by papers focused on Advanced Glycation End Products research (13 papers), Chronic Kidney Disease and Diabetes (8 papers) and Protease and Inhibitor Mechanisms (6 papers). Maria Warwas collaborates with scholars based in Poland and Germany. Maria Warwas's co-authors include Agnieszka Piwowar, Maria Knapik‐Kordecka, Jolanta Zuwała−Jagiełło, Monika Pazgan−Simon, Krzysztof Simon, W Dobryszycka, Jakub Gburek, Marek Nowak, Maciej Siewiński and Joanna Osada and has published in prestigious journals such as Cellular and Molecular Life Sciences, Journal of Pharmacy and Pharmacology and Archives of Toxicology.

In The Last Decade

Maria Warwas

56 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Warwas Poland 13 143 130 108 97 89 59 624
Sayaka Arakawa Japan 11 183 1.3× 97 0.7× 77 0.7× 59 0.6× 139 1.6× 36 731
L. Selmeci Hungary 14 174 1.2× 53 0.4× 148 1.4× 103 1.1× 122 1.4× 51 705
Elena Cercas Spain 14 160 1.1× 96 0.7× 91 0.8× 181 1.9× 123 1.4× 17 646
Eman Salah Egypt 15 196 1.4× 61 0.5× 102 0.9× 38 0.4× 79 0.9× 33 679
Akira Mima Japan 12 310 2.2× 136 1.0× 153 1.4× 98 1.0× 54 0.6× 19 903
Khaled Khazim Israel 13 312 2.2× 94 0.7× 106 1.0× 75 0.8× 75 0.8× 16 878
Ji Eun Lee South Korea 11 128 0.9× 68 0.5× 95 0.9× 75 0.8× 42 0.5× 17 499
Mathias M. Mueller Austria 11 165 1.2× 91 0.7× 105 1.0× 71 0.7× 38 0.4× 16 582
Fabio Gianiorio Italy 9 220 1.5× 95 0.7× 94 0.9× 71 0.7× 37 0.4× 10 706
Lihua Li China 17 306 2.1× 65 0.5× 99 0.9× 104 1.1× 84 0.9× 42 717

Countries citing papers authored by Maria Warwas

Since Specialization
Citations

This map shows the geographic impact of Maria Warwas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Warwas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Warwas more than expected).

Fields of papers citing papers by Maria Warwas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Warwas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Warwas. The network helps show where Maria Warwas may publish in the future.

Co-authorship network of co-authors of Maria Warwas

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Warwas. A scholar is included among the top collaborators of Maria Warwas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Warwas. Maria Warwas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gburek, Jakub, et al.. (2016). Acemannan – properties and medical utility. Postępy Fitoterapii. 1 indexed citations
2.
Żurawska-Płaksej, Ewa, Agnieszka Piwowar, Maria Knapik‐Kordecka, & Maria Warwas. (2013). Activities of Neutrophil Membrane-bound Proteases in Type 2 Diabetic Patients. Archives of Medical Research. 45(1). 36–43. 7 indexed citations
3.
Warwas, Maria & Agnieszka Piwowar. (2011). Urinary cystatin C as a biomarker of renal tubular injury. Postępy Higieny i Medycyny Doświadczalnej. 65. 562–568. 7 indexed citations
4.
Piwowar, Agnieszka, Maria Knapik‐Kordecka, & Maria Warwas. (2010). Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clinical and investigative medicine. 33(2). E109–E116. 20 indexed citations
5.
Zuwała−Jagiełło, Jolanta, et al.. (2008). [Fluorescence of age in serum in detecting liver cirrhosis and hepatocellular carcinoma among patients with anti-HCV antibodies].. PubMed. 62(2). 393–400. 4 indexed citations
6.
Piwowar, Agnieszka, et al.. (2008). Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes/Metabolism Research and Reviews. 24(7). 549–553. 30 indexed citations
7.
Piwowar, Agnieszka, Maria Knapik‐Kordecka, & Maria Warwas. (2008). Ischemia‐Modified albumin level in type 2 diabetes mellitus—Preliminary report. Disease Markers. 24(6). 311–317. 87 indexed citations
8.
Warwas, Maria, et al.. (2007). Serum concentration of cystatin and antitrypsin activity in chicken infection diseases.. Medycyna Weterynaryjna. 63(10). 1216–1219. 3 indexed citations
9.
Piwowar, Agnieszka, Maria Knapik‐Kordecka, & Maria Warwas. (2007). AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 77(2). 188–192. 76 indexed citations
10.
Warwas, Maria, et al.. (2007). [Molecular aspects of aminoglycoside nephrotoxicity].. PubMed. 61. 511–8. 3 indexed citations
11.
Gburek, Jakub, et al.. (2006). Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.. PubMed. 5(3). 223–9. 24 indexed citations
12.
Zuwała−Jagiełło, Jolanta, et al.. (2006). Advanced Glycation Endproducts in Serum of Patients with Chronic Hepatitis and Liver Cirrhosis. Advances in Clinical and Experimental Medicine. 15(2). 259–264. 3 indexed citations
13.
Gburek, Jakub, et al.. (2006). Characterization of chicken cystatin binding to rat renal brush-border membranes. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 146(4). 482–488. 6 indexed citations
14.
Piwowar, Agnieszka & Maria Warwas. (2001). [Cystatin C as a marker of glomerular filtration rate].. PubMed. 55(5). 687–98. 3 indexed citations
15.
Gburek, Jakub, et al.. (2001). Changes in chicken egg white cystatin concentration and isoforms during embryogenesis. British Poultry Science. 42(3). 394–398. 10 indexed citations
16.
Piwowar, Agnieszka, Maria Knapik‐Kordecka, & Maria Warwas. (2000). Concentration of Leukocyte Elastase in Plasma and Polymorphonuclear Neutrophil Extracts in Type 2 Diabetes. Clinical Chemistry and Laboratory Medicine (CCLM). 38(12). 1257–61. 31 indexed citations
17.
Warwas, Maria, et al.. (1997). Cathepsin B-Like Activity as a Serum Tumour Marker in Ovarian Carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM). 35(4). 301–4. 29 indexed citations
18.
Gburek, Jakub, et al.. (1995). Clearance of chicken cystatin from the rat circulation. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 112(4). 697–701. 4 indexed citations
19.
Warwas, Maria & Joanna Osada. (1985). Changes of the level of proteinase inhibitors in rat plasma during turpentine-induced inflammation. Cellular and Molecular Life Sciences. 41(5). 633–634. 5 indexed citations
20.
Dobryszycka, W, et al.. (1979). Serum enzymes in ovarian carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(6). 737–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sayaka Arakawa Breakdown of academic impact, for papers by L. Selmeci Breakdown of academic impact, for papers by Elena Cercas Breakdown of academic impact, for papers by Eman Salah Breakdown of academic impact, for papers by Akira Mima Breakdown of academic impact, for papers by Khaled Khazim Breakdown of academic impact, for papers by Ji Eun Lee Breakdown of academic impact, for papers by Mathias M. Mueller Breakdown of academic impact, for papers by Fabio Gianiorio Breakdown of academic impact, for papers by Lihua Li
Rankless by CCL
2026